Eli Lilly (LLY)

$915.01 13.21 (1.46%)

19:00 EST LLY Stock Quote Delayed 30 Minutes

3 Pharma Stocks to Sell in February Before They Crash and Burn

By Ian Bezek, InvestorPlace Contributor Feb 2, 2024

The good times are coming to an end for these overpriced pharma stocks to sell this month before they crash and burn.

Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for January 2024

3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024

5 Mega-Cap Stocks Ready to Make the Magnificent 7 a Dynamic Dozen

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 3.03M

Day's Range $896.60 - $922.43

52-Week Range $711.40 - $972.53

Dividend & Yield $5.20 (0.57%)

LLY Stock Predictions, Articles, and Eli Lilly News

Portfolio Protection: 7 Risky Stocks to Drop Right Now

By Thomas Niel, InvestorPlace Contributor Jan 12, 2024

Ahead of further or unforeseen challenges, if you own any of these seven risky stocks, now's the time to bail.

Q1’s Rising Stars: 3 Dividend Stocks with Massive Upside

By Chris Markoch, InvestorPlace Contributor Jan 8, 2024

Even if risk-on sentiment returns to market, there are still several catalysts nudging investors to look for dividend stocks to buy

3 Stocks to Make You the Millionaire Next Door: 2024 Edition

By Joel Baglole, InvestorPlace Contributor Jan 5, 2024

Investors wanting to maximize the gains in their portfolio should take a position in one of these leading companies.

2024’s Power Players: 7 Stocks Racing to a Trillion Valuation

By Thomas Niel, InvestorPlace Contributor Jan 1, 2024

Whether in 2024, or in the years ahead, each of these seven stocks could become the next trillion dollar companies.

3 Ken Griffin Stocks to Invest Like Citadel

By Alex Sirois, InvestorPlace Contributor Dec 30, 2023

Invest like Citadel founder and billionaire Ken Griffin with these stocks that have strong potential heading into 2024.

Looking Beyond Tech: 7 High-Growth Stocks for Substantial Returns

By Muslim Farooque, InvestorPlace Contributor Dec 22, 2023

Place your bets on these high-growth stocks beyond tech in 2024, for a more balanced and innovative investment portfolio.

The New Magnificent 7: 7 Stocks Rising to Prominence

By Alex Sirois, InvestorPlace Contributor Dec 15, 2023

The next magnificent 7 stocks continue to rise to prominence and offer strong returns to investors and are generally stable.

Future Trillion-Dollar Companies: 7 Stocks to Invest in Now

By Muslim Farooque, InvestorPlace Contributor Dec 10, 2023

Spotlight on future trillion-dollar stocks; the seven companies that are leading the race in financial and market dominance

Challenging the Magnificent 7: 3 Stocks on the Rise

By Shane Neagle, InvestorPlace Contributor Dec 8, 2023

The S&P 500 is performing well thanks largely to the Magnificent 7. Here are three companies whose stocks could soon join the exclusive club.

3 Healthcare Stocks to Scoop Up as They Change the Medical Landscape

By Joel Baglole, InvestorPlace Contributor Nov 22, 2023

Consider one of these three leading-edge healthcare stocks from companies focused on significant medical innovations.

Why It’s Time to Sell These 3 Hot Stocks

By Joel Baglole, InvestorPlace Contributor Nov 14, 2023

Holding onto a stock too long can lead to an evaporation of profits. Better for investors to sell a little too early than a little too late.

The Magnificent Seven: 7 Stocks That Could Make It the ‘Elite Eight’

By Alex Sirois, InvestorPlace Contributor Nov 13, 2023

Investors curious to identify the next magnificent 7 stock should start here as the clues are fairly straightforward

3 Stocks to Buy for Retirees Looking to Beat Inflation

By Joel Baglole, InvestorPlace Contributor Nov 10, 2023

Retired investors looking to weather the current market with above-average returns should buy these inflation-beating retirement stocks.

7 Biotech Stocks to Buy for Big-Time Gains

By Louis Navellier and the InvestorPlace Research Staff Nov 10, 2023

Biotech stocks can be big winners because they're at the forefront of scientific innovation and push the boundaries of medical research.

The Importance of Brand Power: 3 Stocks to Consider

By Joel Baglole, InvestorPlace Contributor Nov 3, 2023

Count on these companies, whose reputations and brands are growing, leading their popular brand stocks to new heights.

7 A-Rated Tech Stocks to Buy for November

By Louis Navellier and the InvestorPlace Research Staff Nov 2, 2023

By investing in tech stocks, investors can capitalize on groundbreaking technological advancements and be a part of the future.

7 A-Rated Stocks to Buy in Q4

By Louis Navellier and the InvestorPlace Research Staff Oct 31, 2023

Even if you don’t believe in Santa Claus, there’s plenty of reason to believe you can fill your stockings with A-rated stocks to buy this…

AI-Powered Investing: 3 Promising Stocks for 2024

By Will Ashworth, InvestorPlace Contributor Oct 31, 2023

With the further commoditization of asset management, stock predictions by AI have become far more prevalent.

7 Healthcare Stocks That Can Cure a Lackluster Portfolio

By Joel Baglole, InvestorPlace Contributor Oct 19, 2023

Take a position in these companies' stocks to achieve long-term gains and give a jolt to your investment portfolio.

The Next Trillion-Dollar Companies: 3 Stocks to Buy Now

By Muslim Farooque, InvestorPlace Contributor Oct 18, 2023

The spotlight is on these three next trillion-dollar companies expected to continue growing at a rapid pace.

Eli Lilly (LLY)

3 Pharma Stocks to Sell in February Before They Crash and Burn

Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for January 2024

3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024

5 Mega-Cap Stocks Ready to Make the Magnificent 7 a Dynamic Dozen

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Eli Lilly (LLY)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

LLY Stock Predictions, Articles, and Eli Lilly News

Subscriber Sign in